24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.

NCT05299593 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: tafluprost/timolol

Sponsor

Fondazione G.B. Bietti, IRCCS